Estados financieros detallados de Aura Biosciences, Inc. (AURA): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $6.73, AURA presenta beneficios negativos (P/E no significativo) y un ROE del -73.18%. La capitalización bursátil es de $696M.
Cuenta de Resultados (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $509000 | 0 | 0 | 0 | $1.3M | 0 | 0 |
| Beneficio Bruto | -$509000 | 0 | 0 | 0 | -$1.3M | 0 | 0 |
| I+D | $19.1M | $18.0M | $25.2M | $42.2M | $63.9M | $73.3M | $90.3M |
| Generales y Administrativos | $4.5M | $4.2M | $10.1M | $18.1M | $19.8M | $22.8M | $22.5M |
| Gastos Operativos | $23.6M | $22.2M | $35.2M | $60.3M | $83.7M | $96.1M | $112.8M |
| Beneficio Operativo | -$24.1M | -$22.2M | -$35.2M | -$60.3M | -$85.0M | -$96.1M | -$112.8M |
| EBITDA | -$23.7M | -$21.4M | -$34.4M | -$57.6M | -$75.0M | -$85.6M | -$105.0M |
| Gastos por Intereses | $5000 | $3000 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$24.2M | -$22.2M | -$35.3M | -$58.8M | -$76.3M | -$86.8M | -$106.1M |
| Impuestos | 0 | 0 | 0 | 0 | $137000 | $112000 | $108000 |
| Beneficio Neto | -$24.2M | -$22.2M | -$35.3M | -$58.8M | -$76.4M | -$86.9M | -$106.2M |
| BPA | $-0.01 | $-1.03 | $-1.58 | $-1.96 | $-1.93 | $-1.75 | $-1.76 |
| BPA Diluido | $-0.01 | $-1.03 | $-1.58 | $-1.96 | $-1.93 | $-1.75 | $-1.76 |
| Acciones en Circulación (Diluidas) | $2.92B | $29.2M | $29.2M | $29.9M | $39.6M | $49.7M | $60.3M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | 0 | 0 |
| Beneficio Operativo | -$27.9M | -$27.2M | -$34.9M | -$48.1M |
| EBITDA | -$25.8M | -$25.3M | -$32.5M | -$48.1M |
| Beneficio Neto | -$26.1M | -$25.6M | -$33.7M | -$45.6M |
| BPA | $-0.40 | $-0.40 | $-0.50 | $-0.48 |
| BPA Diluido | $-0.40 | $-0.40 | $-0.50 | $-0.48 |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $32.5M | $17.4M | $149.1M | $121.6M | $41.1M | $31.7M | $59.5M |
| Inversiones a Corto | 0 | 0 | 0 | $67.2M | $185.1M | $119.4M | $84.7M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $33.3M | $18.5M | $153.7M | $196.7M | $231.8M | $160.6M | $149.7M |
| Inmovilizado Material | $3.6M | $3.6M | $6.2M | $26.0M | $22.0M | $20.6M | $18.5M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $37.1M | $22.1M | $160.0M | $223.9M | $255.1M | $182.5M | $169.4M |
| Cuentas por Pagar | $2.3M | $611000 | $2.4M | $2.9M | $1.8M | $2.3M | $1.5M |
| Deuda a Corto | 0 | $15000 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $6.1M | $2.7M | $7.4M | $10.5M | $12.4M | $14.9M | $18.4M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | $14.1M |
| Pasivos Totales | $6.3M | $2.7M | $7.7M | $28.4M | $29.2M | $30.5M | $32.5M |
| Reservas | -$94.7M | -$116.9M | -$152.1M | -$210.9M | -$287.3M | -$374.2M | -$480.4M |
| Patrimonio Neto | $30.8M | $19.4M | $152.3M | $195.6M | $225.8M | $152.0M | $136.9M |
| Deuda Total | $49000 | $15000 | $975000 | $20.9M | $19.6M | $18.8M | $17.4M |
| Deuda Neta | -$32.4M | -$17.4M | -$148.1M | -$168.0M | -$206.6M | -$132.3M | -$126.9M |
| Capital Circulante | $27.2M | $15.8M | $146.3M | $186.2M | $219.4M | $145.7M | $131.4M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $47.6M | $59.5M | $84.8M | $67.8M |
| Activos Totales | $190.0M | $169.4M | $137.7M | $348.1M |
| Pasivos Totales | $33.4M | $32.5M | $30.4M | $32.9M |
| Patrimonio Neto | $156.7M | $136.9M | $107.2M | $315.3M |
| Deuda Total | $17.8M | $17.4M | $17.0M | $16.6M |
Flujo de Caja (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$24.2M | -$22.2M | -$35.3M | -$58.8M | -$76.4M | -$86.9M | -$106.2M |
| Amortizaciones | $509000 | $831000 | $831000 | $1.2M | $1.3M | $1.2M | $1.1M |
| Compensación en Acciones | $507000 | $736000 | $2.3M | $6.4M | $8.8M | $11.7M | $14.3M |
| Cambio en Capital Circulante | $2.5M | -$3.7M | -$315000 | -$3.1M | $4.4M | -$2.6M | $6.0M |
| Flujo de Caja Operativo | -$20.7M | -$24.3M | -$32.4M | -$54.6M | -$63.8M | -$79.8M | -$84.7M |
| Inversiones (CapEx) | -$2.2M | -$771000 | -$2.1M | -$1.1M | -$709000 | -$1.3M | -$447000 |
| Adquisiciones | 0 | 0 | 0 | $66775 | 0 | 0 | 0 |
| Recompra de Acciones | -$13000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$22.9M | -$25.1M | -$34.5M | -$55.7M | -$64.6M | -$81.1M | -$85.2M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$20.1M | -$20.5M | -$29.9M | -$31.8M |
| Inversiones (CapEx) | -$45000 | -$176000 | -$102000 | -$21000 |
| Flujo de Caja Libre | -$20.2M | -$20.6M | -$30.0M | -$31.8M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $3.7M | $3.3M | $3.8M | $12.4M |
Crecimiento y Márgenes (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Beneficio Neto (anual) | | +8.2% | -58.7% | -66.7% | -30.0% | -13.8% | -22.2% |
| Crecimiento BPA (anual) | | -12309.6% | -53.4% | -24.1% | +1.5% | +9.3% | -0.6% |
| Cambio en Acciones (anual) | | -99.0% | -0.0% | +2.5% | +32.3% | +25.3% | +21.5% |
| Crecimiento FCF (anual) | | -9.6% | -37.6% | -61.3% | -15.9% | -25.6% | -5.1% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.2% | -0.1% | -0.1% |
Datos por Acción (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.01 | $-0.86 | $-1.18 | $-1.86 | $-1.63 | $-1.63 | $-1.41 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $2.92B | $29.2M | $29.2M | $29.9M | $39.6M | $49.7M | $60.3M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -73.18% |
| Rentabilidad sobre capital invertido | -41.61% |
| Rentabilidad sobre activos | -37.63% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.05 |
| Ratio corriente | 16.82 |
| Piotroski F-Score | 1 |
| Altman Z-Score | 0.83 |
Ratios Clave (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -1783.13 | -14.37 | -10.75 | -5.36 | -4.59 | -4.70 | -3.10 |
| P/VC | 1405.75 | 22.33 | 3.26 | 1.61 | 1.55 | 2.69 | 2.40 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |